Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Workforce, Diseases, Therapies, Adverse Events, Technology and Procedures
ASH Guideline Implementation to Improve Pain Management of Sickle Cell Disease
Jori E. May and colleagues observed frequent deviation from guideline-supported care in patients with suspicion for and with confirmed heparin-induced thrombocytopenia (HIT). In response, they developed an electronic consultation (e-consultation) system (the “HIT E-consult Service”), in which a hematologist was automatically consulted on all patients with a positive screening immunoassay for HIT.
Jordan Schaefer and colleagues participated in a quality improvement project starting between October of 2017 and June of 2018 at six diverse clinical sites. They were able to implement an ASH guideline recommendation to reduce excess aspirin use among patients anticoagulated for VTE and sustain this effort over several years.
Andres Vasconez Samaniego and colleagues investigated the average time to first analgesic dose delivery in the Pediatric ED to patients with Sickle Cell Disease SCD vaso-occlusive pain events and found it was higher than the national recommendation. The most current guidelines from the National Heart Lung Blood Institute and ASH were utilized to streamline pain management in the Pediatric Emergency Department.